1. Katz LA, Spiro HM. Gastrointestinal manifestations of diabetes. N Engl J Med 1966; 275: 1350 – 61.
2. Goyal RK, Spiro HM. Gastrointestinal manifestations of diabetes mellitus. Med Clin N Am 1971; 55: 1031 – 44.
3. Taub S, Mariani A, Barkin JS. Gastrointestinal manifestations of diabetes mellitus. Diabetes Care 1979; 2: 437 – 47.
4. Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983; 98: 378 – 84.
5. Atkinson M, Hosking DJ. Gastrointestinal complications of diabetes mellitus. Clin Gastroenterol 1983; 2: 633 – 50.
6. Yang R, Arem R, Chan L. Gastrointestinal tract complications of diabetes mellitus. Arch Intern Med 1984; 144: 1251 – 6.
7. Niakan E, Harati Y, Comstock JP. Diabetic autonomic neuropathy. Metabolism 1986; 35: 224 – 34.
8. Nompleggi D, Bell SJ, Blackburn GL, Bistrian BR. Overview of gastrointestinal disorders due to diabetes mellitus: emphasis on nutritional support. J Parent Ent Nutr 1989; 13: 84 – 91.
9. Rothstein RD. Gastrointestinal motility disorders in diabetes mellitus. Am J Gastroenterol 1990; 85: 782 – 5.
10. Locke GR III. Epidemiology of gastrointestinal complications of diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7: 711 – 16.
11. Talley NJ, Hammer J, Giles N, Jones MP, Horowitz M. Measuring gastrointestinal symptoms in diabetes: development and validation of the Diabetes Bowel Symptom Questionnaire. Gastroenterology (abstr) 2001 (in press).
12. Horowitz M, Fraser R. Disordered gastric motor function in diabetes mellitus. Diabetologia 1994; 37: 543 – 51.
13. Horowitz M, Wishart JM, Jones KL, Hebbard GS. Gastric emptying in diabetes: an overview. Diabet Med 1996; 13: S16 – 22.
14. Rothman KJ. A proposal to calculate publication equivalents. Epidemiology 1999; 10: 664 – 5.
15. Rundles RW. Diabetic neuropathy: general review with report of 125 cases. Medicine 1945; 24: 111 – 60.
16. Hodges FJ, Rundles RW, Hanelin J. Roentgenologic study of the small intestine II. Dysfunction associated with neurologic disease. Radiology 1947; 49: 659 – 73.
17. Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 1989; 84: 868 – 72.
18. Ko GT, Chan WB, Chan JC, Tsang LW, Cockram CS. Gastrointestinal symptoms in Chinese patients with type 2 diabetes mellitus. Diabet Med 1999; 16: 670 – 74.
19. Maxton DG, Whorwell PJ. Functional bowel symptoms in diabetes – the role of autonomic neuropathy. Postgrad Med J 1991; 67: 991 – 3.
20. Dandona P, Fonseca V, Mier A, Beckett AG. Diarrhea and metformin in a diabetic clinic. Diabetes Care 1983; 6: 472 – 4.
21. Keshavarzian A, Iber FL. Gastrointestinal involvement in insulin-requiring diabetes mellitus. J Clin Gastroenterol 1987; 9: 685 – 92.
22. Maser RE, Pfeifer MA, Dorman JS, Kuller LH et al. Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh epidemiology of diabetes complications study III. Arch Intern Med 1990; 150: 1218 – 22.
23. Enck P, Rathmann W, Spiekermann M, Czerner D et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol 1994; 32: 637 – 41.
24. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817 – 24.
25. Schvarcz E, Palmfier M, Ingberg CM, . Aman J, Berne C. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med 1996; 13: 478 – 81.
26. Janatuinen E, Pikkarainen P, Laakso M, Pyorala K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol 1993; 28: 427 – 32.
27. Spangeus A, El-Salhy M, Suhr O, Eriksson J, Lithner F. Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients. Scand J Gastroenterol 1999; 34: 1196 – 202.
28. Ricci JA, Siddique R, Stewart WF, Sandler RS et al. Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes. Scand J Gastroenterol 2000; 35: 152 – 9.
29. Maleki D, Locke GR III, Camilleri M, Zinsmeister AR et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000; 160: 2808 – 16.
30. Hammer J, Willson T, Horowitz M, Talley NJ. Prevalence and determinants of chronic gastrointestinal symptoms in diabetes mellitus. Gastroenterology 1999; 116: A63.
31. Bytzer PM, Talley NJ, Hammer J, Young LJ et al. Gastrointestinal symptoms in diabetes mellitus are associated with both poor glycaemic control and diabetic complications. Am J Gastroenterol 2002; 97: 604 – 11.
32. Bytzer PM, Talley NJ, Leemon M, Young LJ et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15 000 adults. Arch Intern Med 2001; 161: 1989 – 96.
33. Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology 1980; 79: 283 – 88.
34. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927 – 34.
35. Talley NJ, Weaver AL, Zinsmeister AR Melton LJ III. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 1 – 13.
36. Agr.eus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 671 – 80.
37. Weir RD, Backett EM. Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer. Gut 1968; 9: 75 – 83.
38. Talley NJ. Why do functional gastrointestinal disorders come and go? Dig Dis Sci 1994; 39: 673 – 77.
39. Talley NJ, Howell S, Jones MP, Horowitz M. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2002; 97: 3087 – 94.
40. Horowitz M, Maddox AF, Wishart JM, Harding PE et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991; 18: 229 – 34.
41. Wegener M, Borsch G, Schaffstein J, Luerweg C, Leverkus F. Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus. Dig Dis 1990; 8: 23 – 6.
42. Keshavarzian A, Iber FL, Vaeth J. Gastric emptying in patients with insulin-requiring diabetes mellitus. Am J Gastroenterol 1987; 82: 29 – 35.
43. Horowitz M, Harding PE, Maddox AF,Wishart JM et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 151 – 9.
44. Nowak TV, Johnson CP, Kalbeisch JH, Roza AM et al. Highly variable gastric emptying in patients with insulin-dependent diabetes mellitus. Gut 1995; 37: 23 – 9.
45. Phillips WT, Schwartz JG, McMahan CA. Rapid gastric emptying of an oral glucose solution in type 2 diabetic patients. J Nucl Med 1992; 33: 1496 – 500.
46. Schwartz JG, Green GM, Guan D, McMahan CA, Phillips WT. Rapid gastric emptying of a solid pancake meal in type 2 diabetic patients. Diabetes Care 1996; 19: 468 – 71.
47. Jones KL, Horowitz M, Carney BI, Wishart JM et al. Gastric emptying in ‘early’ noninsulin- dependent diabetes mellitus. J Nucl Med 1996; 37: 1643 – 8.
48. Kim CH, Kennedy FP, Camilleri M, Zinsmeister AR, Ballard DJ. The relationship between clinical factors and gastrointestinal dysmotility in diabetes mellitus. J Gastrointest Motil 1991; 3: 268 – 72.
49. Iber FL, Parveen S, Vandrunen M, Sood KB et al. Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes. Dig Dis Sci 1993; 38: 45 – 50.
50. Mearin F, Malagelada J-R. Gastroparesis and dyspepsia in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7: 717 – 23.
51. Horowitz M, Edelbroek M, Fraser R, Maddox A, Wishart J. Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment. Scand J Gastroenterol 1991; 26: 673 – 84.
52. Holtmann G, Goebell H, Talley NJ. Gastrointestinal sensory function in functional dyspepsia. Gastroenterology 1995; 109: 331 – 2.
53. Samsom M, Salet GAM, Roelofs JMM, Akkermans LMA et al. Compliance of the proximal stomach and dyspeptic symptoms in patients with type 1 diabetes mellitus. Dig Dis Sci 1995; 40: 2037 – 42.
54. Hebbard GS, Sun WM, Dent J, Horowitz M. Acute hyperglycaemia increases proximal gastric compliance. Gastroenterology 1994; 106: A509.
55. Schvarcz E, Palmer M, . Aman J, Lindkvist B, Beckman K-W. Hypoglycaemia increases the gastric emptying rate in patients with type 1 diabetes mellitus. Diabet Med 1993; 10: 660 – 63.
56. Hebbard GS, Sun WM, Dent J, Horowitz M. Hyperglycaemia affects gastric motor and sensory function in normal subjects. Eur J Gastroenterol Hepatol 1996; 8: 211 – 17.
57. Hebbard GS, Samsom M, Sun WM, Dent J, Horowitz M. Hyperglycaemia affects proximal gastric motor and sensory function during small intestinal nutrient infusion. Am J Physiol 1996; 271: G814 – 19.
58. Chey WD, Kim M, Hasler W, Owyang C. Hyperglycaemia alters perception of rectal distension and blunts the recto-anal inhibitory reflex in healthy volunteers. Gastroenterology 1995; 108: 1700 – 708.
59. Drossman DA, McKee DC, Sandler RS, Mitchell CM et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and non-patients with irritable bowel syndrome. Gastroenterology 1988; 95: 701 – 8.
60. Whitehead WE, Bosmajian L, Zonderman AB, Costa PT Jr, Schuster MM. Symptoms of psychological distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988; 95: 709 – 14.
61. Talley NJ, Phillips SF, Bruce B, Twomey CK et al. Relation among personality and symptoms in non-ulcer dyspepsia and the irritable bowel syndrome. Gastroenterology 1990; 99: 327 – 33.
62. Zighelboim J, Talley NJ. What are functional bowel disorders? Gastroenterology 1993; 104: 1196 – 201.
63. Drossman DA, Richter JE, Talley NJ, Thompson WG et al. (eds). The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment – A Multinational Consensus. Little, Brown: Boston, 1994
64. Skenzay JA, Bigler ED. Psychological adjustment and neuropsychological performance in diabetic patients. J Clin Psychol 1985; 41: 391 – 6.
65. Lustman PJ, Grith LS, Clouse RE et al.. Psychiatric illness in diabetes mellitus: relationship to symptoms and glucose control. J Nerv Ment Dis 1986; 174: 736 – 42.
66. Popkin MK, Callies AL, Lentz RD et al.. Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type 1 diabetes mellitus. Arch Gen Psychiat 1988; 45: 64 – 70.
67. Wilkinson G, Borsey DQ, Leslie P, Newton RW et al. Psychiatric morbidity and social problems in patients with insulin-dependent diabetes mellitus. Br J Psychiat 1988; 153: 38 – 43.
68. Rubin RR, Peyrot M. Psychological problems and interventions in diabetes. A review of the literature. Diabetes Care 1992; 15: 1640 – 57.
69. Lustman PJ, Grifth LS, Gavard JA, Clouse RE. Depression in adults with diabetes. Diabetes Care 1992; 15: 1631 – 9.
70. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care 1993; 16: 1167 – 78.
71. Mazze RS, Lucido D, Shamoon H. Psychological and social correlates of glycaemic control. Diabetes Care 1984; 7: 360 – 66.
72. Lustman PJ, Frank BL, McGill JB. Relationship of personality characteristics to glucose regulation in adults with diabetes. Psychosom Med 1991; 53: 305 – 12.
73. Winocour PH, Main CJ, Medlicott G, Anderson DC. A psychometric evaluation of adult patients with type 1 (insulin-dependent) diabetes mellitus: prevalence of psychological dysfunction and relationship to demographic variables, metabolic control and complications. Diabetes Res 1990; 14: 171 – 6.
74. Viinamaki H, Niskanen L, Uusitupa M. Mental well-being in people with non-insulindependent diabetes. Acta Psychiatr Scand 1995; 92: 392 – 7.
75. Clouse RE, Lustman PJ, Reidel WL. Correlation of oesophageal motility abnormalities with neuropsychiatric status in diabetics. Gastroenterology 1986; 90: 1146 – 54.
76. Clouse RE, Lustman PJ. Psychiatric illness and contraction abnormalities of the oesophagus. N Engl J Med 1983; 309: 1337 – 42.
77. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734 – 9.
78. Diepersloot RJA, Bouter KP, Beyer WEP, Hoekstra JBL, Masurel N. Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia 1987; 30: 397 – 401.
79. Nolan CM, Beaty HN, Bagdale JD. Further characterisation of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 1978; 27: 889 – 94.
80. Glass EJ, Stewart J, Matthews DM, Collier A et al. Impairment of monocyte ‘lectinlike’ receptor activity in type 1 (insulin-dependent) diabetic patients. Diabetologia 1987; 30: 228 – 31.
81. Hussein MJ, Alviggi L, Millwand BA, Leslie RDG et al. Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes mellitus may be genetically determinated. Diabetologia 1987; 30: 907 – 11.
82. Ohno Y, Aoki N, Nishimura A. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-α. in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 77: 1072 – 7.
83. Oldenburg B, Diepersloot RJA, Hoekstra JBL. High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 1996; 41: 458 – 61.
84. Marrollo M, Latella G, Melideo D, Iannarelli R et al. Helicobacter pylori and peptic lesions prevalence is increased in diabetes mellitus patients. Gastroenterology 1997; 112: A212.
85. De Luis DA, de la Calle H, Roy G, de Argila CM et al. Helicobacter pylori infection and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1998; 39: 143 – 6.
86. Gasbarrini A, Ojetti V, Pitocco D, De Luca A et al. Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol 1998; 10: 469 – 72.
87. Dore MP, Bilotta M, Malaty HM, Pacico A et al. Diabetes mellitus and Helicobacter pylori infection. Nutrition 2000; 16: 407 – 10.
88. Xia HH, Talley NJ, Kam EP, Young LJ et al. Helicobacter pylori infection is not increased or linked to upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96:1039 – 46.
89. Dimenas E, Glise H, Hallerback B, Hernqvist H et al. Quality of life in patients with upper gastrointestinal symptoms: an improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681 – 7.
90. Stewart AL, Greeneld S, Hays RD. Functional status and well-being of patients with chronic conditions. J Am Med Assoc 1989; 262: 907 – 13.
91. Gill TM, Feinstein AR. A critical reappraisal of the quality of quality-of-life measurements. J Am Med Assoc 1994; 272: 619 – 26.
92. Moyer CA, Fendrick AM. Measuring HRQL in patients with upper gastrointestinal disease. Dig Dis Sci 1998; 16: 315 – 24.
93. Jacobson Am, Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type 1 and type 2 diabetes. Diabetes Care 1994; 17: 269 – 272.
94. Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG. A comparison of global vs. disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997; 20: 299 – 305.
95. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000; 95: 67 – 71.
96. Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999; 231(suppl): 48 – 54.
97. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995; 40: 584 – 9.
98. Cutts TF, Abell TL, Karas JG, Kuns J. Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia. Dig Dis Sci 1996; 41: 1369 – 78.
99. Guyatt G, Mitchell A, Irvine EJ, Singer J et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804 – 10.
100. Patrick DL, Drossman DA, Frederick IO, Discesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development of a new measure. Dig Dis Sci 1998; 43: 400 – 411.
101. Wong E, Guyatt GH, Cook DJ, Grifth LE, Irvine EJ. Development of a questionnaire to measure quality of life in patients with irritable bowel syndrome. Eur J Surg 1998; 583(suppl): 50 – 56.
102. Drossman DA, Patrick DL, Whitehead WE, Toner BB et al. Further validation of the IBS – QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000; 95: 999 – 1007.
103. Wiklund IK, Junghard O, Grace E, Talley NJ et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg 1998; 583 (Suppl): 41 – 9.
104. Dimenas E, Glise H, Hallerback B, Hernqvist H et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30: 1046 – 52.
105. Rockwood TH, Church JM, Fleshman JW, Kane RL et al. Fecal incontinence quality of life scale. Dis Colon Rectum 2000; 43: 9 – 17.
106. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol 1999; 94: 2390 – 7.
107. Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol 1997; 32: 1083 – 9.
108. Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998; 104: 252 – 8.
109. Havelund T, Lind T, Wiklund I, Glise H et al. Quality of life in patients with heartburn but without esophagitus: effects of treatment with omeprazole. Am J Gastroenterol 1999; 94: 1782 – 9.
110. Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999; 13: 1621 – 30.
111. Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998; 43: 2398 – 404.
112. Silvers D, Kipnes M, Broadstone V, Patterson D et al. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA Study Group. Clin Ther 1998; 20: 438 – 53.
113. Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 1997; 92: 976 – 80.
114. Drossman DA. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am J Med 1999; 107(5A): 41 – 50S.
115. Mathias JR, Clench MH, Abell TL, Koch KL et al. Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study. Dig Dis Sci 1998; 43: 1347 – 55.
116. Snijders F, de Boer JB, Steenbergen B, Schouten M et al. Impact of diarrhoea and faecal incontinence on the daily life of HIV-infected patients. AIDS Care 1998; 10: 620 – 37.
117. O’Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol Med Sci 1995; 50: M184 – 9.
118. Sailer M, Bussen D, Fuchs KH, Thiede A. Quality of life in patients with fecal incontinence. Langenbecks Arch Chir Suppl Kongressbd 1998; 115: 973 – 5.
119. Sailer M, Bussen D, Debus ES, Fuchs KH, Thiede A. Quality of life in patients with benign anorectal disorders. Br J Surg 1998; 85: 1716 – 9.
120. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997; 20: 562 – 7.
121. Mazze RS, Lucido D, Shamoon H. Psychological and social correlates of glycemic control. Diabetes Care 1984; 7: 360 – 66.
122. Hathaway DK, Abell TL, Cardoso S, Hartwig MS et al. Improvement in autonomic and gastric function following pancreas – kidney vs. kidney-alone transplantation and the correlation with quality of life. Transplantation 1994; 57: 816 – 22.
123. Denth JPH, Engel LGJB. Diabetic gastroparesis: a critical reappraisal of new treatment strategies. Drugs 1992; 44: 537 – 53.
124. Talley NJ, Young L, Hammer J, Leemon M et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol 2001; 96: 71 – 6.
125. Siddique R, Ricci JA, Stewart WF, Sloan S, Farup CE. Quality of life in a US national sample of adults with diabetes and motility-related upper gastrointestinal symptoms. Dig Dis Sci 2002; 47: 683 – 9.
126. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. J Am Med Assoc 1998; 280: 1490 – 96.
127. Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis – clinical characteristics and long-term outcomes. Am J Gastroenterol 1997; 92: 1501 – 4.
128. Rashed H, Abell TL, Cardoso S, Cutts T et al. Autonomic function testing correlates with response to domperidone therapy in patients with diabetes mellitus and the symptoms of gastroparesis. Diabetes 1997; 381 A.
129. Aggarwal A, Cutts T, Abell TL, Cardoso S et al. Predominant symptoms in the irritable bowel syndrome may correlate with specific abnormalities of the autonomic nervous system. Gastroenterology 1994; 106: 945 – 50.
130. Farup CE, Leidy NK, Murray M, Williams GR et al. Effect of domperidone on the
health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care 1998; 21: 1699 – 706.
131. Prakash A, Wagstaff AJ. Domperidone: a review of its use in diabetic gastropathy. Drugs 1998; 56: 429 – 45.
132. Familoni BO, Abell TL, Voeller G, Salem A, Gaber O. Electrical stimulation at a higher frequency than basal rate in human stomach. Dig Dis Sci 1997; 42: 885 – 91.
133. Rashed H, Luo J, Cutts T, Abell TL. Practitioner-rated score (ADAPS) correlates with symptom severity in patients with severe dyspepsia treated with long-term device, prokinetics and behavioural treatment. Neurogastroenterol Motil 2000; 12: 492.
